We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 3,866.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMDPH
RNS Number : 9157Z
Dechra Pharmaceuticals PLC
23 September 2020
23 September 2020
Dechra(R) Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on 21 September 2020, the following PDMRs exercised nil cost options over ordinary shares of 1p each in the Company. The options were granted to them on 2 March 2018 pursuant to the Dechra Pharmaceuticals PLC Long Term Incentive Plan (the LTIP). The exercise of the options was subject to the achievement of performance conditions which were satisfied to the extent that the options vested at 73.7%. Ian Page and Tony Griffin sold sufficient shares (acquired pursuant to the exercise) in order to fund the resulting tax liability. In accordance with the Company's Directors' Remuneration Policy, the remaining shares must be retained for a period of two years from the date of vesting.
Hot Features
Premium
Name Capacity Options Shares Sold Sale Price Total beneficial Percentage
Exercised per share shareholding of issued
following this share capital
announcement
Ian Page Director 29,409 13,864 GBP31.48220 638,919 0.591%
Tony Griffin Director 8,916 4,472 GBP31.48220 75,050 0.069%
In connection with the exercise, Ian Page's tax qualifying option over 1,197 shares granted on 2 March 2018 at an exercise price of GBP25.06 lapsed.
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Forms
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
---------------------------------- ---------------------------------------
2. Reason for the notification
---------------------------------------------------------------------------
a) Position/status Director/PDMR
---------------------------------- ---------------------------------------
b) Initial notification/ Initial Notification
amendment
---------------------------------- ---------------------------------------
3. Details of the Issuer
---------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
---------------------------------- ---------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
---------------------------------- ---------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
---------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
---------------------------------- ---------------------------------------
b) Nature of the Exercise of 29,409 options under the
transaction Company's Long Term Incentive Plan
---------------------------------- ---------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPNil Cost 29,409
---------------------------------- ---------------------- ---------------
d) Aggregated information
* Aggregate volume
N/A
* Price
---------------------------------- ---------------------------------------
e) Date of the transaction 2020.09.21
---------------------------------- ---------------------------------------
f) Place of the transaction Outside a trading venue
---------------------------------- ---------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Ian Page
---------------------------------- ------------------------------------------
2. Reason for the notification
------------------------------------------------------------------------------
a) Position/status Director/PDMR
---------------------------------- ------------------------------------------
b) Initial notification/ Initial Notification
amendment
---------------------------------- ------------------------------------------
3. Details of the Issuer
------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
---------------------------------- ------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
---------------------------------- ------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
---------------------------------- ------------------------------------------
b) Nature of the Partial sale of shares obtained under
transaction the Company's Long Term Incentive Plan
to satisfy tax liability
---------------------------------- ------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP 31.4822 13,864
---------------------------------- ------------------------ ----------------
d) Aggregated information
* Aggregate volume 13,864
GBP 31.4822
* Price GBP436,469.22
* Total
---------------------------------- ------------------------------------------
e) Date of the transaction 2020.09.22
---------------------------------- ------------------------------------------
f) Place of the transaction London Stock Exchange
---------------------------------- ------------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
------------------------------------- --------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------
a) Position/status Director/PDMR
------------------------------------- --------------------------------------
b) Initial notification/ Initial Notification
amendment
------------------------------------- --------------------------------------
3. Details of the Issuer
-----------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
------------------------------------- --------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
------------------------------------- --------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-----------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
------------------------------------- --------------------------------------
b) Nature of the Exercise of 8,916 options under the
transaction Company's Long Term Incentive Plan
------------------------------------- --------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBPnil 8,916
------------------------------------- ------------------ ------------------
d) Aggregated information
* Aggregate volume
N/A
* Price
------------------------------------- --------------------------------------
e) Date of the transaction 2020.09.21
------------------------------------- --------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------- --------------------------------------
1. Details of the Person Discharging Managerial Responsibility
("PDMR")/person closely associated with them ("PCA")
a) Name Tony Griffin
----------------------------------- ----------------------------------------------
2. Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Director/PDMR
----------------------------------- ----------------------------------------------
b) Initial notification/ Initial Notification
amendment
----------------------------------- ----------------------------------------------
3. Details of the Issuer
-----------------------------------------------------------------------------------
a) Name Dechra Pharmaceuticals PLC
----------------------------------- ----------------------------------------------
b) LEI code 213800J4UVB5OWG8VX82
----------------------------------- ----------------------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place
where transactions have been conducted
-----------------------------------------------------------------------------------
a) Description of Ordinary Shares of 1 pence each
the financial
instrument
ISIN: GB0009633180
Identification
code
----------------------------------- ----------------------------------------------
b) Nature of the Sale of shares obtained under the Company's
transaction Long Term Incentive Plan .
----------------------------------- ----------------------------------------------
c) Price(s) and volumes(s) Price(s) Volume(s)
GBP31.4822 4,472
----------------------------------- ------------------------- -------------------
d) Aggregated information
* Aggregate volume 4,472
GBP 31.4822
* Price GBP140,788.40
* Total
----------------------------------- ----------------------------------------------
e) Date of the transaction 2020.09.22
----------------------------------- ----------------------------------------------
f) Place of the transaction London Stock Exchange
----------------------------------- ----------------------------------------------
For further information, please contact:
Melanie Hall, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHKKNBDQBKDFCB
(END) Dow Jones Newswires
September 23, 2020 10:19 ET (14:19 GMT)
1 Year Dechra Pharmaceuticals Chart |
1 Month Dechra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
